Angiotensin II type 1 receptor blockade ameliorates proteinuria in puromycin aminonucleoside nephropathy by inhibiting the reduction of NEPH1 and nephrin.

Takahashi, Aya

Angiotensin II type 1 receptor blockade ameliorates proteinuria in puromycin aminonucleoside nephropathy by inhibiting the reduction of NEPH1 and nephrin. [electronic resource] - Journal of nephrology Dec 2014 - 627-34 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1724-6059

10.1007/s40620-014-0147-z doi


Angiotensin II Type 1 Receptor Blockers--pharmacology
Animals
Biphenyl Compounds--pharmacology
Disease Models, Animal
Disease Progression
Female
Gene Expression Regulation
Intracellular Signaling Peptides and Proteins--metabolism
Irbesartan
Kidney Glomerulus--drug effects
Membrane Proteins--genetics
Nephrosis, Lipoid--chemically induced
Proteinuria--chemically induced
Puromycin Aminonucleoside
Rats, Wistar
Receptor, Angiotensin, Type 1--drug effects
Tetrazoles--pharmacology
Time Factors